Presentation TCT 2016 Beyond Hypertension: Autonomic Modulation Therapies for "Outside the Box" Conditions Presenter: Elazer R. Edelman, Krishna J. Rocha-Singh, Adam Witkowski October 30, 2016
Presentation TCT 2016 Beyond Hypertension: Autonomic Modulation Therapies for Arrhythmias Presenter: Elazer R. Edelman, Krishna J. Rocha-Singh, Vivek Y. Reddy October 30, 2016
Presentation TCT 2016 Beyond Hypertension: Autonomic Modulation Therapies for Chronic Heart Failure Presenter: Elazer R. Edelman, Krishna J. Rocha-Singh, Farrell O. Mendelsohn October 30, 2016
Presentation TCT 2016 Median Nerve Stimulation for Refractory Hypertension: Valencia Technologies Presenter: Ajay J. Kirtane, Bryan Williams, William B. White October 30, 2016
Presentation TCT 2016 Pacing-based Treatments of Hypertension: BackBeat Medical Presenter: Ajay J. Kirtane, Bryan Williams, Karl-Heinz Kuck October 30, 2016
Presentation TCT 2016 Shunt-based Technologies for Hypertension Control: The Rox Medical Program Presenter: Ajay J. Kirtane, Bryan Williams, Paul A. Sobotka October 30, 2016
Presentation TCT 2016 Carotid Barostimulation to Treat Hypertension (Vascular Dynamics): Mobius HD and the CALM Studies Presenter: Ajay J. Kirtane, Bryan Williams, Wilko Spiering October 30, 2016
Presentation TCT 2016 Carotid Sinus Stimulation: Critical Analysis of the 1st and 2nd Generation CVRx Device Results Presenter: Ajay J. Kirtane, Bryan Williams, Atul Pathak October 30, 2016
Presentation TCT 2016 Why are These Trials Recruiting Slowly and How Can We Improve Recruitment Rates? Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Martin B. Leon October 30, 2016
Presentation TCT 2016 Assessment and Critical Appraisal of Ongoing RDN Studies: Will the Results Accurately Reflect RDN Effectiveness? Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Justin E. Davies October 30, 2016
Presentation TCT 2016 Alcohol Chemical Neurolysis (Ablative Solutions): Peregrine Results and the Sham-controlled TARGET BP I Trial Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, David E. Kandzari October 30, 2016
Presentation TCT 2016 TCT 500: Global Right Ventricular Longitudinal Peak Systolic Strain Predicts clinical Outcome After Pulmonary Artery Denervation for Patients with Pulmonary Arterial Hypertension Presenter: Irene M. Lang, Ehtisham Mahmud October 30, 2016
Presentation TCT 2016 Device Overview and Ongoing Study Design: Kona WAVE IV Trial Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Roland E Schmieder October 30, 2016
Presentation TCT 2016 Device Overview and Ongoing Study Design: Recor RADIANCE HTN Study Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Laura Mauri October 30, 2016
Presentation TCT 2016 Device Overview and Ongoing Study Design: St. Jude's EnligHTN Program Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, William B. White October 30, 2016
Presentation TCT 2016 Device Overview and Ongoing Study Design: Medtronic GLOBAL SYMPLICITY SPYRAL HTN Trial Program Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, David E. Kandzari October 30, 2016
Presentation TCT 2016 TCT 769: Ultrasound-Assisted Catheter-Directed Thrombolysis in the Treatment of High Risk Pulmonary Embolism: A Meta-Analysis Presenter: Irene M. Lang, Ehtisham Mahmud October 30, 2016
Presentation TCT 2016 Device Overview and Ongoing Study Design: Boston Scientific REINFORCE Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Ajay J. Kirtane October 30, 2016
Presentation TCT 2016 Overcoming Clinical Design Issues: What to Look for (and Demand) in Ongoing and Future Hypertension Device Trials Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Bryan Williams October 30, 2016
Presentation TCT 2016 TCT 825: Simplicity Denervation System for Pulmonary Artery Denervation in Patients with Chronic Thrombembolic Pulmonary Hypertension (first-in-man study) Presenter: Irene M. Lang, Ehtisham Mahmud October 30, 2016